Takeda Pharmaceutical Company Limited (TAK)

Growth

Revenue 5Y0.60%
Revenue 3Y1.56%
EPS 5Y0.02%
EPS 3Y9.07%
Dividend 5Y0.02%
Dividend 3Y6.89%

Capital Efficiency

ROIC3.03%
ROE3.55%
ROA1.46%
ROTA2.05%

Capital Structure

Market Cap48.87B
EV3.99T
Cash798.14B
Current Ratio1.15
Debt/Equity0.54
Net Debt/EBITDA3.81
Show More

Income Statement

Select a metric from the list below to chart it

Mar '00
Mar '04
Mar '08
Mar '12
Mar '16
Mar '20
Income Statement
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
TTM
Revenue
13,172.8
13,843.5
14,073.6
13,487.1
13,786.7
16,330.6
25,627.7
24,900.6
27,791.0
29,195.3
Revenue % Chg.
8.6%
5.1%
1.7%
-4.2%
2.2%
18.5%
56.9%
-2.8%
11.6%
10.2%
Cost of Revenue
3,817.6
4,056.8
4,169.1
4,350.9
3,861.6
5,136.9
8,485.7
7,742.4
8,618.8
9,251.6
Cost of Revenue % Chg.
9.5%
6.3%
2.8%
4.4%
-11.2%
33.0%
65.2%
-8.8%
11.3%
16.1%
Gross Profit
9,355.2
9,786.7
9,904.6
9,136.2
9,925.1
11,193.7
17,142.0
17,158.2
19,172.3
19,943.8
Gross Profit % Chg.
8.3%
4.6%
1.2%
-7.8%
8.6%
12.8%
53.1%
0.1%
11.7%
7.7%
Gross Profit Margin
71.0%
70.7%
70.4%
67.7%
72.0%
68.5%
66.9%
68.9%
69.0%
68.3%
Gross Profit Margin % Chg.
-0.3%
-0.5%
-0.5%
-3.7%
6.3%
-4.8%
-2.4%
3.0%
0.1%
-2.3%
R&D Expenses
2,659.6
2,975.3
2,693.7
2,431.8
2,534.1
2,867.9
3,834.1
3,549.5
4,096.5
4,436.6
R&D Expenses % Chg.
-
11.9%
-9.5%
-9.7%
4.2%
13.2%
33.7%
-7.4%
15.4%
17.5%
Selling, General, & Admin Expenses
-
-
-
-
-
-
-
-
6,901.9
7,278.5
Selling, General, & Admin Expenses % Chg.
-
-
-
-
-
-
-
-
-
5.2%
Other Expenses
5,611.1
7,817.9
6,192.2
5,490.7
5,508.2
7,077.2
11,168.8
10,974.4
4,585.4
5,349.1
Other Expenses % Chg.
-
39.3%
-20.8%
-11.3%
0.3%
28.5%
57.8%
-1.7%
-58.2%
28.3%
Operating Income
1,084.5
-1,006.5
1,018.7
1,213.7
1,882.8
1,596.0
781.9
3,965.6
3,588.5
2,879.7
Operating Income % Chg.
13.7%
-
-
19.1%
55.1%
-15.2%
-51.0%
407.2%
-9.5%
-42.2%
Operating Income Margin
8.2%
-7.3%
7.2%
9.0%
13.7%
9.8%
3.1%
15.9%
12.9%
9.9%
Operating Income Margin % Chg.
4.7%
-
-
24.3%
51.8%
-28.4%
-68.8%
422.0%
-18.9%
-47.5%
Total Other Income/Expenses Net
152.4
-126.0
-80.1
-97.5
-191.4
-857.1
-1,254.9
-1,113.8
-1,232.4
-1,025.1
Total Other Income/Expenses Net % Chg.
171.8%
-
36.4%
21.7%
96.3%
347.7%
46.4%
11.2%
10.7%
14.9%
Income Before Tax
1,236.9
-1,132.5
938.6
1,116.2
1,691.3
738.9
-473.1
2,851.8
2,356.0
1,854.6
Income Before Tax % Chg.
22.5%
-
-
18.9%
51.5%
-56.3%
-
-
-17.4%
-54.6%
Income Before Tax Margin
9.4%
-8.2%
6.7%
8.3%
12.3%
4.5%
-1.8%
11.5%
8.5%
6.4%
Income Before Tax Margin % Chg.
12.7%
-
-
24.1%
48.2%
-63.1%
-
-
-26.0%
-58.9%
Income Tax Expense
383.8
-18.7
288.6
216.7
237.5
-109.9
-818.0
-77.4
563.8
194.4
Income Tax Expense % Chg.
-
-
-
-24.9%
9.6%
-
644.0%
90.5%
-
-51.8%
Net Income
830.5
-1,135.1
624.2
895.0
1,455.2
849.7
344.5
2,927.9
1,791.4
1,659.9
Net Income % Chg.
-18.7%
-
-
43.4%
62.6%
-41.6%
-59.5%
749.9%
-38.8%
-54.9%
Net Income Margin
6.3%
-8.2%
4.4%
6.6%
10.6%
5.2%
1.3%
11.8%
6.4%
5.7%
Net Income Margin % Chg.
-25.2%
-
-
49.6%
59.1%
-50.7%
-74.2%
774.7%
-45.2%
-59.1%
Weighted Avg. Shares Out
1,578.9
1,572.8
1,567.9
1,562.2
1,561.6
1,923.0
3,114.4
3,124.0
3,124.0
3,130.3
Weighted Avg. Shares Out % Chg.
0.0%
-0.4%
-0.3%
-0.4%
-0.0%
23.1%
62.0%
0.3%
-
-0.1%
EPS
0.5
-0.7
0.4
0.6
0.9
0.4
0.1
0.9
0.6
0.5
EPS % Chg.
-18.7%
-
-
43.9%
62.7%
-52.6%
-75.0%
747.3%
-38.8%
-54.9%
Weighted Avg. Shares Out Dil
1,580.7
1,572.8
1,576.4
1,571.7
1,573.4
1,933.8
3,132.4
3,147.1
3,147.1
3,149.8
Weighted Avg. Shares Out Dil % Chg.
0.1%
-0.5%
0.2%
-0.3%
0.1%
22.9%
62.0%
0.5%
-
-0.1%
EPS Diluted
0.5
-0.7
0.4
0.6
0.9
0.4
0.1
0.9
0.6
0.5
EPS Diluted % Chg.
-18.8%
-
-
43.8%
62.4%
-52.5%
-75.0%
745.9%
-38.8%
-54.9%
Interest Income
383.9
119.6
168.5
95.6
307.9
51.5
87.2
13.9
184.5
408.8
Interest Income % Chg.
202.4%
-68.8%
40.9%
-43.3%
222.2%
-83.3%
69.2%
-84.1%
1230.7%
175.3%
Interest Expense
239.2
256.0
248.6
181.0
248.6
375.0
1,160.3
1,018.6
1,297.3
1,331.1
Interest Expense % Chg.
824.5%
7.0%
-2.9%
-27.2%
37.3%
50.8%
209.4%
-12.2%
27.4%
36.7%
EBIT
1,381.6
-1,268.9
858.5
1,030.7
1,750.6
415.5
-1,546.2
1,847.1
1,243.3
932.3
EBIT % Chg.
24.3%
-
-
20.1%
69.8%
-76.3%
-
-
-32.7%
-71.4%
EBIT Margin
10.5%
-9.2%
6.1%
7.6%
12.7%
2.5%
-6.0%
7.4%
4.5%
3.2%
EBIT Margin % Chg.
14.5%
-
-
25.3%
66.2%
-80.0%
-
-
-39.7%
-74.1%
Depreciation & Amortization
1,679.9
2,032.0
1,537.0
1,734.8
1,418.2
2,121.5
4,544.7
4,358.0
4,540.9
4,871.9
Depreciation & Amortization % Chg.
7.3%
21.0%
-24.4%
12.9%
-18.3%
49.6%
114.2%
-4.1%
4.2%
11.2%
EBITDA
3,061.5
763.0
2,395.5
2,765.5
3,168.8
2,537.0
2,998.6
6,205.1
5,784.1
5,804.2
EBITDA % Chg.
14.4%
-75.1%
213.9%
15.4%
14.6%
-19.9%
18.2%
106.9%
-6.8%
-24.1%
EBITDA Margin
23.2%
5.5%
17.0%
20.5%
23.0%
15.5%
11.7%
24.9%
20.8%
19.9%
EBITDA Margin % Chg.
5.3%
-76.3%
208.8%
20.5%
12.1%
-32.4%
-24.7%
113.0%
-16.5%
-31.1%